title: Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation.
authors.affiliation: Renal Unit, University Clinic, University of Navarra, Pamplona, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Garcia
authors.forename: P
authors.initials: P
authors.lastname: Errasti
authors.forename: F J
authors.initials: FJ
authors.lastname: Lavilla
authors.forename: B
authors.initials: B
authors.lastname: Ballester
authors.forename: J
authors.initials: J
authors.lastname: Manrique
authors.forename: E
authors.initials: E
authors.lastname: Rossich
authors.forename: A
authors.initials: A
authors.lastname: Purroy
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use*; D012307:Risk Factors; D013997:Time Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D008055:Lipids; D008074:Lipoproteins; D011725:Pyridines; D002784:Cholesterol; C086276:cerivastatin